Table 3.

Distribution of macrolides, lincosamides, and streptogramins resistance genes by origin of the staphylococcal isolate (community-acquired versus hospital-acquired); p-value < 0.05 is considered as statistically significant.

	Staphylococcus spp., n (%)
	Community-acquired	Hospital-acquired	p-Value
ermA	13 (8.6)	1 (3.4)	0.47
ermB	4 (2.6)	2 (6.9)	0.25
ermC	24 (16.0)	2 (6.9)	0.26
lnuA	7 (4.6)	3 (10.3)	0.21
lsaA	2 (1.3)	0	1.00
msrA/B	34 (22.6)	13 (44.8)	0.02
ermA + ermC	1 (0.6)	0	1.00
ermA + msrA/B	2 (1.3)	0	1.0
ermB + ermC	1 (0.6)	0	1.0
ermB + lsaA	5 (3.3)	1 (3.4)	1.0
ermB + msrA/B	4 (2.6)	0	1.0
ermC + lsaA	1 (0.6)	0	1.0
ermC + msrA/B	7 (4.6)	1 (3.4)	1.0
lnuA + lnuB	1 (0.6)	0	1.0
msrA/B + lsaA	1 (0.6)	0	1.0
ermB + msrA/B + lsaA	0	1 (3.4)	0.16
ermC + msrA/B + lnuA	1 (0.6)	0	1.0
ermB + lnuA + lnuB + lsaA	1 (0.6)	0	1.0
No resistance gene	41 (27.3)	5 (17.2)	0.35
Total	150 (100)	29 (100)